Thromb Haemost 1982; 47(03): 275-277
DOI: 10.1055/s-0038-1657184
Original Article
Schattauer GmbH Stuttgart

Functional Activities and Concentrations of Plasmin Inhibitors in Normal Subjects and D. I. C. Patients

F Velasco
The Department of Hematology, Reina Sofia Hospital, Cordoba, Spain
,
A Torres
The Department of Hematology, Reina Sofia Hospital, Cordoba, Spain
,
P Andres
The Department of Hematology, Reina Sofia Hospital, Cordoba, Spain
,
M I Duran
The Department of Hematology, Reina Sofia Hospital, Cordoba, Spain
› Author Affiliations
Further Information

Publication History

Received 15 December 1981

Accepted 27 April 1982

Publication Date:
13 July 2018 (online)

Summary

Alpha-2-macroglobulin and fast antiplasmin, the main inhibitors of the fibrinolytic system, and the presence of plasmin-antiplasmin complex (P-AP) were studied in 15 DIC patients and in 20 healthy individuals. There was a lack of correlation between immunological and chromogenic substrates alpha-2 antiplasmin levels when P-AP complex were found in DIC patients (in 6/15 cases). The levels of alpha-2-macroglobulin were within the normal range in most of these patients, confirm the secondary role of this inhibitor in fibrinolysis.

 
  • References

  • 1 Aasen AO, Gallimore MJ, Ohlsson K, Amundsen E. Alteration of plasmin activity, plasminogen levels and activity of antiplasmins during endotoxic shock in dogs. Haemostasis 1978; 7: 164-169
  • 2 von Kaulla KN. In: Chemistry of Thrombolysis. Human fibrinolytic Enzymes. 246-247 Thomas, Springfield, Ill, USA: 1973
  • 3 Gallimore JM, Aasen AO, Smith ErichsenN, Larsbraaten M, Lyngaas K, Amundsen E. Plasminogen concentration and functional activities and concentrations in patients with septic shock. Thromb Res 1980; 18: 601-608
  • 4 Collen D. On the regulation and control of fibrinolysis. Thromb Haemostas 1980; 43: 77-89
  • 5 Edy J, Collen D, Verstraete M. Quantitation of the plasma protease inhibitor antiplasmin with the chromogenic substrate S-2251. In: Progress in chemical fibrinolysis and thrombolysis. Vol 3 Davidson JF, Rowan RM, Samama MM, Desnoyers PC. (Eds) Raven Press; New York:
  • 6 Samama M, Schlegel N, Cazenave B, Horellou MH, Conard J, Castel M, Domenias R. Alpha-2 antiplasmin assay: Amidolytic and immunological method critical evaluation. Results in a clinical material. In: Synthetic substrates in Clinical Blood Coagulation Assay. Lijnen HR, Collen D, Verstraete M. (Eds) 93-101 Martinus Nijhoff Publishers; The Haque. Boston - London: 1980
  • 7 Gamba G, Fomasari P, Montani N, Biancardi M, Grignani G, Ascari E. Plasma levels of protease inhibitors in acute myeloid leukemia at the onset of the disease and during antiblastic therapy. Thromb Res 1980; 17: 41-53
  • 8 Friberger P, Knos M, Justavsson S, Aureli L, Claeson G. Methods for the determination of plasmin, antiplasmin and plasminogen by means of the substrate S-2251. Haemostasis 1978; 7: 138-145
  • 9 Teger-Nilsson AC, Friberger P, Gyzander E. Determination of a new rapid plasma inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scan J Clin Lab Invest 1977; 37: 403-404
  • 10 Laurell CN. Quantitative estimation of protein by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
  • 11 Ganrot PO. Crossed Immunoelectrophoresis. Scand J Clin Lab Invest 1972; 29 (Suppl. 00) 124-139
  • 12 Collen D. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. Eur J Biochem 1976; 69: 209-216
  • 13 Moroi M, Aoki N. Isolation and characterization of alpha-2 plasmin inhibitor from human plasma. A novel proteinasa inhibitor with inhibits activator-induced clot lysis. J Biol Chem 1976; 251: 5956-5965
  • 14 Mullertz S, Clemensen I. The primary inhibitor of plasmin in human plasma. Biochem J 1976; 159: 545-553
  • 15 Aoki N. Natural inhibitors of fibrinolysis. Prog Cardiovasc Dis 1979; 21: 267-286
  • 16 Felez J, Borrell M, Fontcuberta J, Rutllan ML. Determinacion del complejo plasmina-antiplasmin en sujetos normales y en el curso del tratamiento fibrinolitico. Biol Clin Hematol 1979; 2: 153-158
  • 17 Collen D, Wiman B. Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma. Blood 1979; 53: 313-324
  • 18 Verstraete M, Vermylen J, Schetz J. Biochemical changes noted during intermittent administration of streptokinase. Thromb Haemo-stas 1978; 39: 61-68
  • 19 Teger-Nilsson AC, Gyzander E, Hedner U, Myrvold H, Noppa H, Olsson R, Wallmo L. Antiplasmin and other inhibitors of fibrinolysis in clinical material. In: Progress in chemical fibrinolysis and thrombolysis. (Vol 3) Davidson JF, Rowan RM, Samama MM, Desnoyers PC. (Eds) 327-335 Raven Press; New York, USA: 1978